HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
REP8839
Description
REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
No brand information found.
